Supporting Gene Therapy Development with Safer, More Efficacious AAV Vectors

resourcesSIRION Biotech GmbH
October 27th 2022

SIRION provides a 360° solution from early R&D up to the late preclinical AAV vector space to develop safe and efficacious AAV-based drug products. Please click on the brochure below to learn more:

Succeed with Sirion

LentiBOOST® - Lentiviral Transduction Enhancer For Clinical Applications